Determination of the antiepileptics vigabatrin and gabapentin in dosage forms and biological fluids using hantzsch reaction

A selective and sensitive method was developed for the determination of the anticonvulsants vigabatrin (I) (CAS 60643-86-9) and gabapentin (II) (CAS 60142-96-3). The method is based on the condensation of the drugs through their amino groups with acetylacetone and formaldehyde according to Hantzsch reaction yilding the highly fluorescent dihydropyridine derivatives. The yellowish-orange color was also measured spectrophotometrically at 410 nm and 415 nm for I and II, respectively. The absorbance-concentration plots were rectilinear over the ranges 10-70 mug/ml and 20-140 mug/ml for I and II, respectively. As for the fluorescence-concentration plots, they were linear over the ranges 0.5-10 mug/ml and 2.5-20 mug/ml with minimum detection limits (SIN = 2) of 0.05 mug/ml( 2.1 x 10 (8) mol/l) and 0.1 mug/ml ( 5.8 x 10 (7) mol/l) for I and II, respectively. The spectrophotometric method was applied to the determination of I and II in their tablets. The percentage recoveries +/- SD (n = 6) were 99.45 +/- 0.13 and 98.05 +/- 0.53, respectively. The spectrofluorimetric method was successfully applied to the determination of I and II in spiked human urine and plasma. The % recoveries +/- SD (n = 5) were 98.77 +/- 0.29 and 98.39 +/- 0.53 for urine and 99.32 +/- 0.74 and 98.90 +/- 0.96 for plasma, for I and II, respectively. No interference was encountered with the co-administered drugs: valproic acid (CAS 99-66-1), diphenylhydantoin (CAS 57-41-0], phenobarbital (CAS 50-06-6), carbamazepine (CAS 298-46-4), clonazepam (CAS 1622-61-3), clohazam ((CAS 22316-47-8) or cimetidine (CAS 51481-61-9). A proposal of the reaction pathway Is suggested. The advantages of the proposed methods over existing method are discussed.